MATNMateon

$0.00
$0.00
(0.00%)
Today
Updated:
Mkt Cap$18.68M
Vol108,017.00
50

Neutral Sentiment

How do you feel about MATN?

About

Oncotelic Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases. It also develops OT-101 for various cancers and COVID-19, Artemisinin for COVID-19 and AI technologies for clinical development and manufacturing. The company was founded in 1988 and is headquartered in Agoura Hills, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
40

Frequently Asked Questions

What is Market Cap of Mateon Therapeutics Inc?
What is the 52-week high for Mateon Therapeutics Inc?
What is the 52-week low for Mateon Therapeutics Inc?
What is Mateon Therapeutics Inc stock price today?
What was Mateon Therapeutics Inc stock price yesterday?
What is the PE ratio of Mateon Therapeutics Inc?
What is the Price-to-Book ratio of Mateon Therapeutics Inc?
What is the 50-day moving average of Mateon Therapeutics Inc?
How many employees does Mateon Therapeutics Inc have?

Latest MATN News

View
Top Discussions

Advertisement|Remove ads.